Basic Information
| RNALocate ID: | RLID-D:11000666 |
| RNA Symbol: | hsa-miR-342-5p |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-342-5p |
| RNA ID: | miRBase:MIMAT0004694 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| Tissue/Cell Line: | Fibroblasts|Mesenchymal stem cells |
| Database: | EVmiRNA |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002632 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:11003905 | Exosome | Primary dendritic cells | 21505438 |
| RLID:11003906 | Exosome | Plasma | 23663360 |
| RLID:11003907 | Exosome | Plasma|Serum | 24683445 |
| RLID:11003908 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11001537 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-342-5p | Ovarian clear cell carcinoma | MNDR-E-MI-42175 |
| MNDR | hsa-miR-342-5p | Lymphoma | MNDR-E-MI-42176 |
| MNDR | hsa-miR-342-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-42177 |
| MNDR | hsa-miR-342-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-42178 |
| MNDR | hsa-miR-342-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-42179 |
| MNDR | hsa-miR-342-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-42180 |
| MNDR | hsa-miR-342-5p | Breast cancer luminal | MNDR-E-MI-42181 |
| MNDR | hsa-miR-342-5p | Gastric cancer | MNDR-E-MI-42182 |
| MNDR | hsa-miR-342-5p | Alzheimer disease | MNDR-E-MI-42183 |
| MNDR | hsa-miR-342-5p | Seizures | MNDR-E-MI-42184 |
| MNDR | hsa-miR-342-5p | Leukemia | MNDR-E-MI-42185 |
| MNDR | hsa-miR-342-5p | Cardiovascular disease | MNDR-E-MI-42186 |
| MNDR | hsa-miR-342-5p | Lung cancer | MNDR-E-MI-42187 |
| MNDR | hsa-miR-342-5p | Parkinson disease | MNDR-E-MI-42188 |
| MNDR | hsa-miR-342-5p | Basal-like breast cancer | MNDR-E-MI-42189 |
| MNDR | hsa-miR-342-5p | Pancreatic cancer | MNDR-E-MI-42190 |
| MNDR | hsa-miR-342-5p | Melanoma | MNDR-E-MI-42191 |
| MNDR | hsa-miR-342-5p | Rectum adenocarcinoma | MNDR-E-MI-42192 |
| MNDR | hsa-miR-342-5p | Nephroblastoma | MNDR-E-MI-42193 |
| MNDR | hsa-miR-342-5p | Colon cancer | MNDR-E-MI-42194 |
| MNDR | hsa-miR-342-5p | Colon adenocarcinoma | MNDR-E-MI-42195 |
| MNDR | hsa-miR-342-5p | Relapsing-remitting multiple sclerosis | MNDR-E-MI-42196 |
| MNDR | hsa-miR-342-5p | Familial ovarian cancer | MNDR-E-MI-42197 |
| MNDR | hsa-miR-342-5p | Prostate adenocarcinoma | MNDR-E-MI-42198 |
| MNDR | hsa-miR-342-5p | Carcinoma ductal breast | MNDR-E-MI-42199 |
| MNDR | hsa-miR-342-5p | Glioblastoma | MNDR-E-MI-42200 |
| MNDR | hsa-miR-342-5p | Glioma | MNDR-E-MI-42201 |
| MNDR | hsa-miR-342-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-42202 |
| MNDR | hsa-miR-342-5p | Osteosarcoma | MNDR-E-MI-42203 |
| MNDR | hsa-miR-342-5p | Breast carcinoma | MNDR-E-MI-42204 |
| MNDR | hsa-miR-342-5p | Liver cancer | MNDR-E-MI-42205 |
| MNDR | hsa-miR-342-5p | Gastric adenocarcinoma | MNDR-E-MI-42206 |
| MNDR | hsa-miR-342-5p | Bone-invasive pituitary adenoma | MNDR-E-MI-42207 |
| MNDR | hsa-miR-342-5p | Lung squamous cell carcinoma | MNDR-E-MI-42208 |
| MNDR | hsa-miR-342-5p | Lung adenocarcinoma | MNDR-E-MI-42209 |
| MNDR | hsa-miR-342-5p | Pancreatic adenocarcinoma | MNDR-E-MI-42210 |
| MNDR | hsa-miR-342-5p | Carcinoma renal cell | MNDR-E-MI-42211 |
| MNDR | hsa-miR-342-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-42212 |
| MNDR | hsa-miR-342-5p | Renal clear cell carcinoma | MNDR-E-MI-42213 |
| MNDR | hsa-miR-342-5p | Esophageal cancer | MNDR-E-MI-42214 |
| MNDR | hsa-miR-342-5p | Lung small cell carcinoma | MNDR-E-MI-42215 |
| MNDR | hsa-miR-342-5p | Synovial sarcoma | MNDR-E-MI-42216 |
| MNDR | hsa-miR-342-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-42217 |
| MNDR | hsa-miR-342-5p | Testicular germ cell cancer | MNDR-E-MI-42218 |
| MNDR | hsa-miR-342-5p | Breast invasive carcinoma | MNDR-E-MI-42219 |
| MNDR | hsa-miR-342-5p | Hepatocellular carcinoma | MNDR-E-MI-42220 |
| MNDR | hsa-miR-342-5p | Familiar ovarian carcinoma | MNDR-E-MI-42221 |
| MNDR | hsa-miR-342-5p | Rheumatoid arthritis | MNDR-E-MI-42222 |
| MNDR | hsa-miR-342-5p | Neuroblastoma | MNDR-E-MI-42223 |
| MNDR | hsa-miR-342-5p | Burkitt lymphoma | MNDR-E-MI-42224 |
| MNDR | hsa-miR-342-5p | Skin cutaneous melanoma | MNDR-E-MI-42225 |
| MNDR | hsa-miR-342-5p | Skin melanoma | MNDR-E-MI-42226 |
| MNDR | hsa-miR-342-5p | Colorectal cancer | MNDR-E-MI-42227 |
| MNDR | hsa-miR-342-5p | Multiple myeloma | MNDR-E-MI-42228 |
| MNDR | hsa-miR-342-5p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-42229 |
| MNDR | hsa-miR-342-5p | Stroke lacunar | MNDR-E-MI-42230 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ENG | Homo sapiens | RR00500169 |
TOP